Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis. - Wikidata - wikimedia - TriplyDB

Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.

Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.

http://www.wikidata.org/entity/Q36969836

about

Comparative pharmacodynamics of posaconazole in neutropenic murine models of invasive pulmonary aspergillosis and mucormycosis.Human Fungal Pathogens of Mucorales and Entomophthorales.An integrated genomic and transcriptomic survey of mucormycosis-causing fungi NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.CotH3 mediates fungal invasion of host cells during mucormycosis.Antifungal drug development: challenges, unmet clinical needs, and new approaches.Mucormycoses caused by Lichtheimia species.Clinical Analysis of Diabetic Combined Pulmonary Mucormycosis.Isavuconazole therapy protects immunosuppressed mice from mucormycosis.Ketoacidosis alone does not predispose to mucormycosis by Lichtheimia in a murine pulmonary infection model.Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.Monotherapy or combination therapy of isavuconazole and micafungin for treating murine mucormycosis.VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus Infection.Inhibition of EGFR Signaling Protects from Mucormycosis

P2860

Q34596761-A459D7AA-0677-4E9F-A20F-CB0D94F6F300 Q35245238-B55F3A0C-0585-405A-9396-846DB531D961 Q37128028-20CC5A3A-162F-44B7-B6D9-CE0617D450CA Q37399422-1BF989A9-CC5E-4881-B39C-2E23C4D4500E Q37410618-D36E71D7-86EA-4068-8E66-BFFED315E6C3 Q37717926-44E93E5B-8624-412F-A8B4-A43FD4A152D9 Q38245952-2D8EFB31-E7AD-474F-9394-25E8E6C554D2 Q38699198-44E928D1-92B8-42A5-B482-CD5888BA9995 Q39684037-2889D897-C639-45BA-9A06-1A3A06B21B8E Q40116878-F03AFEE0-9331-42F3-900C-C50035EEEF08 Q40157268-75CBEA42-BE09-48AE-B5CB-E127B79A8B6D Q40306219-6718E9B3-6CA2-4271-B67C-497BCB8B2213 Q40474311-FD09EBEA-EF06-4786-843C-969BB8FFC400 Q41000467-75F47B26-7F5F-45F4-8823-306E490565BA Q58207282-1CE4351C-89F8-45CF-AB55-441DB03A7BB1

P2860

Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.

http://www.wikidata.org/entity/Q36969836

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Efficacy of liposomal amphoter ...... models of murine mucormycosis.

@en

type

label

Efficacy of liposomal amphoter ...... models of murine mucormycosis.

@en

prefLabel

Efficacy of liposomal amphoter ...... models of murine mucormycosis.

@en

P1433

Q36969836-399E9F00-28C2-4CD3-992B-451865BDFBFD

P1476

Q36969836-357E52A9-1EDC-44D5-AA13-3E4EFE85C516

P2093

Q36969836-184ADA76-F179-45C4-9522-BD96E6ED45D2

Q36969836-1EC001DB-AFD1-4A17-B748-67E96ED70ACB

Q36969836-54F58895-8034-4047-9E42-30FF8FD57A29

Q36969836-552AA603-7DAB-4EB3-830F-6FF1933498DC

Q36969836-74B2C233-8583-43A3-B0BD-BCF85477E9F9

Q36969836-BDA0D1EA-F6B0-4D4C-B1E3-416FC49BE8A9

Q36969836-EEADB81F-5DF2-47B4-A979-AAFFA727E4E3

Q36969836-F7AB5D5C-48F1-425D-BCCB-9C93BF5EEE09

P2860

Q36969836-080FEB43-C72E-4300-813A-E293025E6F7C

Q36969836-0B5FDA68-65B0-419A-AC4D-447322254382

Q36969836-0FF56CAB-2E70-4568-AB35-2C380E87D7B3

Q36969836-1318F3F5-40E4-4094-96FB-F59B0AA1D7D9

Q36969836-173B00DF-49BD-4BE7-8735-4F923C6B8507

Q36969836-1B115066-647B-473D-A9A0-09CECFB4C2DB

Q36969836-25B68579-7539-4F7F-BEC9-490ECA3D8CC3

Q36969836-29CDDCE1-B9AD-42F4-BC06-3D7AB46EC03D

Q36969836-2ADE75A8-3F4B-4F8E-9837-F91FBFC54D1D

Q36969836-2AE34403-981F-4125-88A9-BF9BFE4FF037

P304

Q36969836-F47CDF5B-0AD0-49EB-A534-FE6C9D6ACD5F

P31

Q36969836-E47C6B02-D063-47F1-9A11-39FBE0C9A5BF

P356

Q36969836-D0AF4E87-D146-43ED-904A-1F39F8A09A4B

P407

Q36969836-0713AD78-40F8-4789-A525-32516C29CA9C

P433

Q36969836-DB544148-9AC6-4C4C-B176-F6BB11FF4E67

P478

Q36969836-20806508-D1C0-4CE5-81B1-6F307BF9F972

P577

Q36969836-780D5CF9-1FC2-490B-931B-0A4867992ACF

P698

Q36969836-A4AD6509-17B8-45A1-AA7C-A9833BE0DCB7

P932

Q36969836-A22A5274-0E60-49C4-BCAD-BED0D7DE731F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy of liposomal amphoter ...... models of murine mucormycosis.

@en

P2093

Ashraf S Ibrahim

http://www.w3.org/2001/XMLSchema#string

Guanpingsheng Luo

http://www.w3.org/2001/XMLSchema#string

Hongkyu Lee

http://www.w3.org/2001/XMLSchema#string

Nathan P Wiederhold

http://www.w3.org/2001/XMLSchema#string

Samuel W French

http://www.w3.org/2001/XMLSchema#string

Scott G Filler

http://www.w3.org/2001/XMLSchema#string

Teclegiorgis Gebremariam

http://www.w3.org/2001/XMLSchema#string

Thomas F Patterson

http://www.w3.org/2001/XMLSchema#string

P2860

Genomic analysis of the basal lineage fungus Rhizopus oryzae reveals a whole-genome duplication

Zygomycetes in human disease

Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa

Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species

Rhizopus oryzae adheres to, is phagocytosed by, and damages endothelial cells in vitro

Caspofungin inhibits Rhizopus oryzae 1,3-beta-D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis.

The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice.

Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies.

Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.

P304

3340-3347

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00313-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23650163

http://www.w3.org/2001/XMLSchema#string

P932

3697351

http://www.w3.org/2001/XMLSchema#string